The benefit was consistent in adults with new or existing heart failure and in those with either preserved or reduced ejection fraction (Boehringer Ingelheim)
Diabetes News Service
Glycosmedia is also available as an App:
For iPhone and iPad | For Android devices
Sponsorship and Advertising
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
